GB1183899A - Ethers of the Pregnane Series - Google Patents

Ethers of the Pregnane Series

Info

Publication number
GB1183899A
GB1183899A GB53886/68A GB5388668A GB1183899A GB 1183899 A GB1183899 A GB 1183899A GB 53886/68 A GB53886/68 A GB 53886/68A GB 5388668 A GB5388668 A GB 5388668A GB 1183899 A GB1183899 A GB 1183899A
Authority
GB
United Kingdom
Prior art keywords
group
ols
prepared
hydroxy
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB53886/68A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck KGaA
Original Assignee
E Merck AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19671668444 external-priority patent/DE1668444A1/en
Application filed by E Merck AG filed Critical E Merck AG
Publication of GB1183899A publication Critical patent/GB1183899A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)

Abstract

1,183,899. Steroid 3-ethers of the pregnane series. E. MERCK A.G. 13 Nov., 1968 [13 Dec., 1967], No. 53886/68. Heading C2U. Novel steroids of the formula (wherein R<SP>1</SP> is C 1-10 alkyl or C 3-7 cycloalkyl; and R<SP>2</SP> is a free or esterified OH group) and the ester salts of the acidic and basic 21-esters are prepared (1) by etherification of the corresponding 3-ols or reactive derivatives thereof with appropriate alcohols R<SP>1</SP>OH or reactive derivatives thereof or (2) by removal, by reaction with zinc in aqueous acetic acid, of the 17α-OH group from corresponding steroids containing this group; or (3) by solvolysis or hydrogenolysis of corresponding steroids in which the 20-keto group and/or the 21-R<SP>2</SP> group is or are functionally changed. Free 21-ols may be esterified. Starting materials of the formula are prepared by reduction of the 3-keto group of desoxycorticosterone possibly after esterification or etherification of the 21-hydroxy group and/or conversion of the 20-keto group to a functional derivative, to give a mixture of 3α- and 3#-ols which may be separated and protective groups if present then split off. The mixture of the individual epimers can be converted to reactive derivatives of the 3-ols, e.g. 3-halo compounds or 3-sulphonates, by standard procedures. Starting materials of the formula are prepared by reducing the bis-methylenedioxy derivative of cortexolone (prepared conventionally) to give a mixture of the epimeric 3-ols, splitting off the protecting group and etherifying, if necessary via a 3-ester or similar derivative, the epimers being separated at any appropriate stage. The novel 3-ethers of 3-hydroxy-21-(hydroxy or acyloxy) - 4 - pregnen - 20 - one are stated to possess a sodium-retaining and diuresisinhibiting action of the same order as that of 9α-fluoro-hydrocortisone and therefore to be useful for combatting Adison's disease and hypotonia. They may be made up into pharmaceutical compositions with suitable carriers.
GB53886/68A 1967-12-13 1968-11-13 Ethers of the Pregnane Series Expired GB1183899A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19671668444 DE1668444A1 (en) 1967-12-13 1967-12-13 AEther of the Pregnan Series and Process for Their Production

Publications (1)

Publication Number Publication Date
GB1183899A true GB1183899A (en) 1970-03-11

Family

ID=5686107

Family Applications (1)

Application Number Title Priority Date Filing Date
GB53886/68A Expired GB1183899A (en) 1967-12-13 1968-11-13 Ethers of the Pregnane Series

Country Status (7)

Country Link
US (1) US3597453A (en)
AT (1) AT292209B (en)
BE (1) BE725269A (en)
BR (1) BR6804629D0 (en)
ES (1) ES361360A1 (en)
FR (1) FR8163M (en)
GB (1) GB1183899A (en)

Also Published As

Publication number Publication date
FR8163M (en) 1970-08-24
BR6804629D0 (en) 1973-01-11
ES361360A1 (en) 1970-08-16
US3597453A (en) 1971-08-03
BE725269A (en) 1969-06-11
AT292209B (en) 1971-08-25

Similar Documents

Publication Publication Date Title
GB1190403A (en) 4-Hydroxy-2-Butenoic Acid Lactones
Sarett Stereoisomeric Substituted 11-Keto-20-hydroxypregnanes. I
GB1495531A (en) 11beta-alkyl steroids of the estrane series
GB1183899A (en) Ethers of the Pregnane Series
GB1376892A (en) 2beta-substituted-3alpha-hydroxysteroids and their esters
US3290297A (en) Tetrahydrofuranyl ethers of delta1, 3, 5(10)-estratriene
US3032552A (en) 1-methyl steroids of the androstane series
US3061606A (en) Delta-4-pregnenolones and method
US3062846A (en) (lower alkoxy) methyl ether derivatives of steroids and process therefor
US3143557A (en) Substituted 19-norandrosta-5(10), 9(11)-dienes and method of preparing same
US3242169A (en) 6alpha-dimethylaminomethyl-3-oxo-delta4-steroids and method for producing same
US3214447A (en) 2alpha-methyl-11-oxygenated androstanes and intermediates therefor
US3228933A (en) 3-enol ethers of 6-methyl-3-oxo-deta4-steroids and process for preparing same
US2861085A (en) 19-nordesoxycorticosterone and process therefor
US3565778A (en) Process for the manufacture of beta-hydroxy-steroid-ketones
US3118919A (en) Dienic steroids and method of preparing the same
US2673863A (en) Esters of 20, 21-ketols of the pregnane series with acids of the type of trimethyl acetic acid
GB1185381A (en) 05,16beta-Methylene Steroids of the 19-Nor-Androstane Series and Process for their Manufacture
ES361690A1 (en) 18-methylene-steroids of the pregnane series
US3092626A (en) Process for the manufacture of 16-alkyl-20:21-ketols of the pregnane series
US3053858A (en) 10-fluoro-19-nor steroids
US2989552A (en) 4-organothiomethyl-3-oxo-delta4 steroids and methods for preparing same
GB1022953A (en) New homosteroids and process for their manufacture
US3000912A (en) 2alpha-substituted methyl androstanes
US3377343A (en) 2&#39;, 2&#39;-bistrifluoromethyloxetano(3&#39;, 4&#39;; 16alpha, 17alpha)derivatives of the pregnane series

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PLE Entries relating assignments, transmissions, licences in the register of patents
PLNP Patent lapsed through nonpayment of renewal fees